Effects of Escitalopram on Markers of Bone Turnover: A Randomized Clinical Trial

CONTEXT: Recent observational studies have suggested that the use of selective serotonin reuptake inhibitors is associated with an increased fracture risk and an accelerated bone loss, although conflicting results have been reported. Furthermore, because many of these studies have been performed in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Diem, Susan J., Joffe, Hadine, Larson, Joseph C., Tsai, Joy N., Guthrie, Katherine A., LaCroix, Andrea Z., Ensrud, Kristine E., Freeman, Ellen W., Leder, Benjamin Z.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Endocrine Society 2014
Schlagworte:
JCEM Online: Brief Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4154080/
https://ncbi.nlm.nih.gov/pubmed/25014001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2288
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge